BioXcel Therapeutics, Inc. 10-Q filing
Filed 2025-11-12 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001104659-25-109880
- Form type
- 10-Q
- CIK
- 0001720893
- Primary document
- https://www.sec.gov/Archives/edgar/data/1720893/000110465925109880/btai-20250930x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BioXcel Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $386,000 | - | - |
| Cost Of Revenue | $132,000 | - | - |
| Operating Income | $-40.2M | - | - |
| Net Income | $-57.4M | - | - |
| Eps Basic | -6.38 | - | - |
| Eps Diluted | -6.38 | - | - |
| Cash And Equivalents | $36.2M | - | - |
| Total Assets | $44.8M | - | - |
| Total Liabilities | $133.7M | - | - |
| Shareholders Equity | $-88.9M | - | - |
| Operating Cash Flow | $-43.4M | - | - |
| Capital Expenditures | $0 | - | - |